| 000 | 01688 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514003554.0 | ||
| 264 | 0 | _c20010920 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a0166-3542 | ||
| 024 | 7 |
_a10.1016/s0166-3542(01)00149-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSidwell, R W | |
| 245 | 0 | 0 |
_aInfluence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201. _h[electronic resource] |
| 260 |
_bAntiviral research _cSep 2001 |
||
| 300 |
_a179-87 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAcids, Carbocyclic |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclopentanes _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGuanidines |
| 650 | 0 | 4 |
_aInfluenza A virus _xdrug effects |
| 650 | 0 | 4 |
_aInfluenza B virus _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNeuraminidase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOrthomyxoviridae Infections _xdrug therapy |
| 700 | 1 | _aSmee, D F | |
| 700 | 1 | _aHuffman, J H | |
| 700 | 1 | _aBarnard, D L | |
| 700 | 1 | _aMorrey, J D | |
| 700 | 1 | _aBailey, K W | |
| 700 | 1 | _aFeng, W C | |
| 700 | 1 | _aBabu, Y S | |
| 700 | 1 | _aBush, K | |
| 773 | 0 |
_tAntiviral research _gvol. 51 _gno. 3 _gp. 179-87 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0166-3542(01)00149-8 _zAvailable from publisher's website |
| 999 |
_c11377286 _d11377286 |
||